p53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women

Oncology Research

Volumn 18, Issue 9, 2010, Pages 453-459

  Roh, Ju Won ^a   Kim, Bu Kyung ^b   Lee, Chae Hyeong ^a   Kim, Jongseung ^c   Chung, Hyun Hoon ^d   Kim, Jae Weon ^d   Park, Noh Hyun ^d   Song, Yong Sang ^d   Park, Sang Yoon ^b   Kang, Soon Beom ^d  

^a Dongguk University Ilsan Hospital   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Cervical cancer; p21 codon 31; p53 codon 72; Polymorphism

Indexed keywords

GENOMIC DNA; PROTEIN P21; PROTEIN P53;

ADENOCARCINOMA; ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

EID: 77952404260     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12671222663719     Document Type: Article

References (32)

1. Shin, H. R.; Park, S.; Hwang, S. Y.; Kim, J. E.; Jung, K. W.; Won, Y. J.; Hwang, S. S.; Yim, S. H.; Choi, K. S.; Park, E. C.; Park, S. Y.; Kim, J. W.; Lee, H. P. Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. Int. J. Cancer 122: 393-397; 2008.
2. Walboomers, J. M.; Jacobs, M. V.; Manos, M. M.; Bosch, F. X.; Kummer, J. A.; Shah, K. V.; Snijders, P. J.; Peto, J.; Meijer, C. J.; Munoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19; 1999.
3. el-Deiry, W. S.; Tokino, T.; Velculescu, V. E.; Levy, D. B.; Parsons, R.; Trent, J. M.; Lin, D.; Mercer, W. E.; Kinzler, K. W.; Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825; 1993.
4. Scheffner, M.; Werness, B. A.; Huibregtse, J. M.; Levine, A. J.; Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136; 1990.
5. Storey, A.; Thomas, M.; Kalita, A.; Harwood, C.; Gardiol, D.; Mantovani, F.; Breuer, J.; Leigh, I. M.; Matlashewski, G.; Banks, L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234; 1998.
6. Koushik, A.; Platt, R. W.; Franco, E. L. p53 codon 72 polymorphism and cervical neoplasia: A meta-analysis review. Cancer Epidemiol. Biomarkers Prev. 13:11-22; 2004.
7. Kim, J. W.; Roh, J. W.; Park, N. H.; Song, Y. S.; Kang, S. B.; Lee, H. P. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am. J. Obstet. Gynecol. 184:55-58; 2001.
8. Roh, J. W.; Kim, J. W.; Park, N. H.; Song, Y. S.; Park, I. A.; Park, S. Y.; Kang, S. B.; Lee, H. P. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol. Oncol. 93:499-505; 2004.
9. Chedid, M.; Michieli, P.; Lengel, C.; Huppi, K.; Givol, D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 9:3021-3024; 1994.
10. Birgander, R.; Sjalander, A.; Saha, N.; Spitsyn, V.; Beckman, L.; Beckman, G. The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. Hum. Hered. 46:148-154; 1996.
11. Sun, Y.; Hildesheim, A.; Li, H.; Li, Y.; Chen, J. Y.; Cheng, Y. J.; Hayes, R. B.; Rothman, N.; Bi, W. F.; Cao, Y.; et al. No point mutation but a codon 31ser arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): The polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol. Biomarkers Prev. 4:261-267; 1995.
12. Bhattacharya, P.; Sengupta, S. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol. Oncol. 99: 176-182; 2005.
13. Santos, A. M.; Sousa, H.; Pinto, D.; Portela, C.; Pereira, D.; Catarino, R.; Duarte, I.; Lopes, C.; Medeiros, R. Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur. J. Cancer 42: 958-963; 2006.
14. Roh, J.; Kim, M.; Kim, J.; Park, N.; Song, Y.; Kang, S.; Lee, H. Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett. 165: 59-62; 2001.
15. Kim, J. W.; Song, Y. S.; Jeon, H. W.; Park, N. H.; Kang, S. B.; Lee, H. P. Comparison of HPV 16 sequence variations at upstream regulatory region in the couples of patients with cervical cancer for determination of HPV infectivity. J. Korean Cancer Assoc. 31:403-410; 1999.
16. Hildesheim, A.; Herrero, R.; Castle, P. E.; Wacholder, S.; Bratti, M. C.; Sherman, M. E.; Lorincz, A. T.; Burk, R. D.; Morales, J.; Rodriguez, A. C.; Helgesen, K.; Alfaro, M.; Hutchinson, M.; Balmaceda, I.; Greenberg, M.; Schiffman, M. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br. J. Cancer 84:1219-1226; 2001.
17. Hopkins, M. P.; Morley, G. W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet. Gynecol. 77:912-917; 1991.
18. Brinton, L. A.; Tashima, K. T.; Lehman, H. F.; Levine, R. S.; Mallin, K.; Savitz, D. A.; Stolley, P. D.; Fraumeni, Jr., J. F. Epidemiology of cervical cancer by cell type. Cancer Res. 47:1706-1711; 1987.
19. Zehbe, I.; Voglino, G.; Wilander, E.; Genta, F.; Tommasino, M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354:218-219; 1999.
20. Yang, Y. C.; Chang, C. L.; Chen, M. L. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol. Obstet. Invest. 51:197-201; 2001.
21. Tachezy, R.; Mikyskova, I.; Salakova, M.; Van Ranst, M. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism. Hum. Genet. 105:564-566; 1999.
22. Andersson, S.; Rylander, E.; Strand, A.; Sallstrom, J.; Wilander, E. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br. J. Cancer 85:1153-1156; 2001.
23. Minaguchi, T.; Kanamori, Y.; Matsushima, M.; Yoshikawa, H.; Taketani, Y.; Nakamura, Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 58:4585-4586; 1998.
24. Klug, S. J.; Wilmotte, R.; Santos, C.; Almonte, M.; Herrero, R.; Guerrero, I.; Caceres, E.; Peixoto-Guimaraes, D.; Lenoir, G.; Hainaut, P.; Walboomers, J. M.; Munoz, N. TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol. Biomarkers Prev. 10:1009-1012; 2001.
25. Lee, B. J.; Jeong, D. H.; Lee, K. B.; Sung, M. S.; Kim, K. T. The p53 DNA polymorphism of cervical cancer patients with human papillomavirus 16/18 infection. Korean J. Gynecol. Oncol. Colposc. 13:201-212; 2002.
26. Harima, Y.; Sawada, S.; Nagata, K.; Sougawa, M.; Ostapenko, V.; Ohnishi, T. Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. Int. J. Mol. Med. 7:261-264; 2001.
27. Zakut, R.; Givol, D. The tumor suppression function of p21Waf is contained in its N-terminal half ([half-WAF'). Oncogene 11:393-395; 1995.
28. Helt, A. M.; Funk, J. O.; Galloway, D. A. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J. Virol. 76:10559-10568; 2002.
29. Li, G.; Liu, Z.; Sturgis, E. M.; Shi, Q.; Chamberlain, R. M.; Spitz, M. R.; Wei, Q. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 26:1596-1602; 2005.
30. Powell, B. L.; van Staveren, I. L.; Roosken, P.; Grieu, F.; Berns, E. M.; Iacopetta, B. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis 23:311-315; 2002.
31. Shih, C. M.; Lin, P. T.; Wang, H. C.; Huang, W. C.; Wang, Y. C. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn. J. Cancer Res. 91: 9-15; 2000.
32. Wu, M. T.; Chen, M. C.; Wu, D. C. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett. 205: 61-68; 2004.